New predictors of metastasis in patients with early-stage pancreatic cancer

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Researchers at Weill Cornell Medicine with an international team have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic cancer will spread to an individual's liver or elsewhere, such as the lung.

New predictors of metastasis in patients with early-stage pancreatic cancer retrieved 28 June 2024 from https://medicalxpress.com/news/2024-06-predictors-metastasis-patients-early-stage.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.12 hours agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Weill Cornell Medicine receives $1.5M grant to predict prostate cancer bone metastasisWeill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers identify the initial steps in colorectal cancer formationResearch led by Weill Cornell Medicine provides new evidence that most colorectal cancers begin with the loss of intestinal stem cells, even before cancer-causing genetic alterations appear.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers overturn the prevailing theory for colorectal tumor initiationResearch led by Weill Cornell Medicine provides new evidence that most colorectal cancers begin with the loss of intestinal stem cells, even before cancer-causing genetic alterations appear.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers discover potential new therapy for lethal metabolomic diseaseResearchers at the Abimael Laboratory of Neurometabolism and the Neurometabolomics & Neuroinformatics core at Mount Sinai have discovered a potential new therapy, improved an existing treatment, and identified a disease biomarker in a mouse model of a lethal neurometabolic disease in humans.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers investigate the feasibility of new home-administered treatment for binge eating disorderResearchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London have investigated the feasibility of a new home-administered treatment for binge eating disorder.
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers discover new therapeutic target for the treatment of melanoma resistant to targeted therapiesAn international research team led by scientists from the University of Liège has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies. Inhibition of the VARS enzyme could prevent this therapeutic resistance by resensitizing tumors resistant to these targeted therapies.
Source: medical_xpress - 🏆 101. / 51 Read more »